Noninvasive cell-tracking methods

Nature Reviews Clinical Oncology

Volumn 8, Issue 11, 2011, Pages 677-688

  Kircher, Moritz F ^a   Gambhir, Sanjiv S ^d   Grimm, Jan ^b,c  

^a Department of Radiology ^*  (United States)

^b Molecular Pharmacology and Chemistry Program   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; DENDRITIC CELL VACCINE; FERUMOXYTOL; FLUORODEOXYGLUCOSE F 18; GADOLINIUM CHELATE; GADOLINIUM PENTETATE MEGLUMINE; GANCICLOVIR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHYLGLYOXAL BIS(4 METHYLTHIOSEMICARBAZONE) CU 64; METHYLPREDNISOLONE; OXIQUINOLON IN 111; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTHRITIS; CELL LABELING; CELL MIGRATION; CELL SURFACE; CELL TRACKING; CYTOTOXIC T LYMPHOCYTE; FLUORESCENCE; HERPES SIMPLEX VIRUS 1; HUMAN; INTERNALIZATION; ISOTOPE LABELING; LEUKOCYTE; MAGNETISM; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TERATOMA;

ANIMALS; CELL MOVEMENT; CELL TRACKING; CONTRAST MEDIA; DENDRITIC CELLS; GADOLINIUM; GENES, REPORTER; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUMINESCENT MEASUREMENTS; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; NANOPARTICLES; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 80155150292     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.141     Document Type: Review

References (126)

1. Rosenberg, S. A. et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med. 319, 1676-1680 (1988). (Pubitemid 19015247)
2. Weber, J. et al. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy. Clin. Cancer Res. 17, 1664-1673 (2011).
3. Jha, P. et al. Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities. Cancer Res. 70, 6109-6113 (2010).
4. Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44-55 (2005). (Pubitemid 40385504)
5. Grimm, J., Kircher, M. F. & Weissleder, R. Cell tracking. Principles and applications [German]. Radiologe 47, 25-33 (2007). (Pubitemid 46181577)
6. Kircher, M. F. et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 63, 6838-6846 (2003). (Pubitemid 37322966)
7. Pittet, M. J. et al. In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc. Natl Acad. Sci. USA 104, 12457-12461 (2007). (Pubitemid 47206159)
8. Grimm, J., Swirski, F. K., Pittet, M., Josephson, L. & Weissleder, R. A nanoparticle-based cell labeling agent for cell tracking with SPECT/CT. Mol. Imaging 5, 364 (2006).
9. Zhou, R. et al. In vivo detection of stem cells grafted in infarcted rat myocardium. J. Nucl. Med. 46, 816-822 (2005).
10. Moore, A., Grimm, J., Han, B. & Santamaria, P. Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. Diabetes 53, 1459-1466 (2004). (Pubitemid 38697657)
11. Bettegowda, C. et al. Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc. Natl Acad. Sci. USA 102, 1145-1150 (2005). (Pubitemid 40170740)
12. Blasberg, R. G. & Gelovani, J. Molecular-genetic imaging: a nuclear medicine-based perspective. Mol. Imaging 1, 280-300 (2002).
13. Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740-751 (2004). (Pubitemid 38647915)
14. Tannous, B. A. et al. Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat. Methods 3, 391-396 (2006).
15. Weissleder, R. et al. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 6, 351-355 (2000).
16. Krishnan, M. et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J. 20, 106-108 (2006). (Pubitemid 43100482)
17. Rudelius, M. et al. Highly efficient paramagnetic labelling of embryonic and neuronal stem cells. Eur. J. Nucl. Med. Mol. Imaging 30, 1038-1044 (2003). (Pubitemid 37086949)
18. Bhorade, R., Weissleder, R., Nakakoshi, T., Moore, A. & Tung, C. H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug. Chem. 11, 301-305 (2000). (Pubitemid 30324895)
19. Heckl, S. et al. CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm. Cancer Res. 62, 7018-7024 (2002). (Pubitemid 35424096)
20. Kim, T. et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 133, 2955-2961 (2011).
21. Ward, K. M., Aletras, A. H. & Balaban, R. S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson. 143, 79-87 (2000).
22. Aime, S., Carrera, C., Delli Castelli, D., Geninatti Crich, S. & Terreno, E. Tunable imaging of cells labeled with MRI-PARACEST agents. Angew. Chem. Int. Ed. Engl. 44, 1813-1815 (2005).
23. Shen, T., Weissleder, R., Papisov, M., Bogdanov, A. Jr & Brady, T. J. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 29, 599-604 (1993). (Pubitemid 23138048)
24. Jung, C. W. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13, 675-691 (1995).
25. Wagner, S., Schnorr, J., Pilgrimm, H., Hamm, B. & Taupitz, M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest. Radiol. 37, 167-177 (2002). (Pubitemid 34259726)
26. Shapiro, E. M. et al. MRI detection of single particles for cellular imaging. Proc. Natl Acad. Sci. USA 101, 10901-10906 (2004). (Pubitemid 38989558)
27. Moore, A., Weissleder, R. & Bogdanov, A. Jr. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J. Magn. Reson. Imaging 7, 1140-1145 (1997). (Pubitemid 28372892)
28. Weissleder, R., Cheng, H. C., Bogdanova, A. & Bogdanov, A. Jr. Magnetically labeled cells can be detected by MR imaging. J. Magn. Reson. Imaging 7, 258-263 (1997). (Pubitemid 28365670)
29. Zelivyanskaya, M. L. et al. Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J. Neurosci. Res. 73, 284-295 (2003). (Pubitemid 36918092)
30. Sipe, J. C. et al. Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn. Reson. Imaging 17, 1521-1523 (1999).
31. de Vries, I. J. et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23, 1407-1413 (2005). (Pubitemid 41679393)
32. Saudek, F. et al. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation 90, 1602-1606 (2010).
33. Smirnov, P. et al. In vivo single cell detection of tumor-infiltrating lymphocytes with a clinical 1.5 Tesla MRI system. Magn. Reson. Med. 60, 1292-1297 (2008).
34. Bulte, J. W. et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 96, 15256-15261 (1999). (Pubitemid 30019799)
35. Ahrens, E. T., Feili-Hariri, M., Xu, H., Genove, G. & Morel, P. A. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn. Reson. Med. 49, 1006-1013 (2003). (Pubitemid 36627278)
36. Rettenbacher, L. & Galvan, G. Anaphylactic shock after repeated injection of 99mTc-labeled CEA antibody [German]. Nuklearmedizin 33, 127-128 (1994). (Pubitemid 24225404)
37. Bulte, J. W. et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141-1147 (2001). (Pubitemid 33115700)
38. Modo, M., Hoehn, M. & Bulte, J. W. Cellular MR imaging. Mol. Imaging 4, 143-164 (2005). (Pubitemid 43143788)
39. Daldrup-Link, H. E. et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur. Radiol. 15, 4-13 (2005). (Pubitemid 40109763)
40. Walczak, P., Kedziorek, D. A., Gilad, A. A., Lin, S. & Bulte, J. W. Instant MR labeling of stem cells using magnetoelectroporation. Magn. Reson. Med. 54, 769-774 (2005). (Pubitemid 41457046)
41. Josephson, L., Tung, C. H., Moore, A. & Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10, 186-191 (1999). (Pubitemid 29147720)
42. Lewin, M. et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18, 410-414 (2000). (Pubitemid 30217528)
43. Koch, A. M. et al. Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug. Chem. 14, 1115-1121 (2003). (Pubitemid 37449038)
44. Zhao, M., Kircher, M. F., Josephson, L. & Weissleder, R. Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 13, 840-844 (2002). (Pubitemid 34801127)
45. Vianello, F. et al. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. J. Immunol. 176, 2902-2914 (2006).
46. Suzuki, Y. et al. In vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by off-resonance positive contrast. Magn. Reson. Med. 60, 1269-1275 (2008).
47. Ahrens, E. T., Flores, R., Xu, H. & Morel, P. A. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 23, 983-987 (2005). (Pubitemid 41114032)
48. Partlow, K. C. et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J. 21, 1647-54 (2007). (Pubitemid 46855610)
49. Gustafsson, B., Youens, S. & Louie, A. Y. Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation. Bioconjug. Chem. 17, 538-547 (2006).
50. Swirski, F. K. et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl Acad. Sci. USA 103, 10340-10345 (2006). (Pubitemid 44051168)
51. Harisinghani, M. G. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491-2499 (2003). (Pubitemid 36706536)
52. Guimaraes, A. R. et al. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 71, 708-712 (2008).
53. Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T. & Josephson, L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol. 23, 1418-1423 (2005). (Pubitemid 41679395)
54. Long, C. M., van Laarhoven, H. W., Bulte, J. W. & Levitsky, H. I. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res. 69, 3180-3187 (2009).
55. Genove, G., DeMarco, U., Xu, H., Goins, W. F. & Ahrens, E. T. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 11, 450-454 (2005). (Pubitemid 40562338)
56. Cohen, B. et al. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat. Med. 13, 498-503 (2007). (Pubitemid 46559823)
57. Gilad, A. A. et al. Artificial reporter gene providing MRI contrast based on proton exchange. Nat. Biotechnol. 25, 217-219 (2007). (Pubitemid 46227121)
58. Mempel, T. R. et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25, 129-141 (2006). (Pubitemid 44066829)
59. von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3, 867-878 (2003). (Pubitemid 37411716)
60. Ntziachristos, V., Bremer, C., Graves, E. E., Ripoll, J. & Weissleder, R. In vivo tomographic imaging of near-infrared fluorescent probes. Mol. Imaging 1, 82-88 (2002).
61. Liu, H. et al. Molecular optical imaging with radioactive probes. PLoS ONE 5, e9470 (2010).
62. Ruggiero, A., Holland, J. P., Lewis, J. S. & Grimm, J. Cerenkov luminescence imaging of medical isotopes. J. Nucl. Med. 51, 1123-1130 (2010).
63. Shah, K. & Weissleder, R. Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2, 215-225 (2005). (Pubitemid 40471433)
64. Ntziachristos, V., Ripoll, J., Wang, L. V. & Weissleder, R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol. 23, 313-320 (2005). (Pubitemid 41094419)
65. Lim, Y. T. et al. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol. Imaging 2, 50-64 (2003).
66. Contag, P. R., Olomu, I. N., Stevenson, D. K. & Contag, C. H. Bioluminescent indicators in living mammals. Nat. Med. 4, 245-247 (1998). (Pubitemid 28137381)
67. Welsh, D. K. & Kay, S. A. Bioluminescence imaging in living organisms. Curr. Opin. Biotechnol. 16, 73-78 (2005). (Pubitemid 40249761)
68. Tang, Y. et al. In vivo tracking of neural progenitor cell migration to glioblastomas. Hum. Gene Ther. 14, 1247-1254 (2003). (Pubitemid 37034574)
69. Shcherbo, D. et al. Bright far-red fluorescent protein for whole-body imaging. Nat. Methods 4, 741-746 (2007). (Pubitemid 47338169)
70. Borovjagin, A. V. et al. Noninvasive monitoring of mRFP1-and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol. Imaging 9, 59-75 (2010).
71. Massoud, T. F. & Gambhir, S. S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580 (2003). (Pubitemid 36307540)
72. Adonai, N. et al. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl Acad. Sci. USA 99, 3030-3035 (2002). (Pubitemid 34240580)
73. Bhargava, K. K., Gupta, R. K., Nichols, K. J. & Palestro, C. J. In vitro human leukocyte labeling with 64Cu: an intraindividual comparison with 111In-oxine and 18F-FDG. Nucl. Med. Biol. 36, 545-549 (2009).
74. Brenner, W. et al. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J. Nucl. Med. 45, 512-518 (2004). (Pubitemid 47618629)
75. Kircher, M. F. et al. Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117, 388-395 (2008).
76. Brenner, W. et al. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J. Nucl. Med. 45, 512-518 (2004). (Pubitemid 47618629)
77. Monteiro-Riviere, N. A., Inman, A. O. & Zhang, L. W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234, 222-235 (2009).
78. de Vries, E. F., Roca, M., Jamar, F., Israel, O. & Signore, A. Guidelines for the labelling of leucocytes with 99mTc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur. J. Nucl Med. Mol. Imaging 37, 842-848 (2010).
79. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W. & Prasher, D. C. Green fluorescent protein as a marker for gene expression. Science 263, 802-805 (1994). (Pubitemid 24093206)
80. Rabinovich, B. A. et al. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc. Natl Acad. Sci. USA 105, 14342-14346 (2008).
81. Acton, P. D. & Zhou, R. Imaging reporter genes for cell tracking with PET and SPECT. Q. J. Nucl. Med. Mol. Imaging 49, 349-360 (2005). (Pubitemid 43246284)
82. Mettler, F. A. Jr. & Guiberteau, M. J. Essentials of nuclear medicine imaging 5th Edition (Saunders/Elsevier, Philadelphia, 2006).
83. Gambhir, S. S. et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl Acad. Sci. USA 97, 2785-2790 (2000). (Pubitemid 30159249)
84. Massoud, T. F., Singh, A. & Gambhir, S. S. Noninvasive molecular neuroimaging using reporter genes: part II, experimental, current, and future applications. AJNR Am. J. Neuroradiol. 29, 409-418 (2008). (Pubitemid 351424048)
85. Massoud, T. F., Singh, A. & Gambhir, S. S. Noninvasive molecular neuroimaging using reporter genes: part I, principles revisited. AJNR Am. J. Neuroradiol. 29, 229-234 (2008). (Pubitemid 351287872)
86. Serganova, I., Mayer-Kukuck, P., Huang, R. & Blasberg, R. Molecular imaging: reporter gene imaging. Handb. Exp. Pharmacol. 185, 167-223 (2008).
87. Yaghoubi, S. S. et al. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nat. Clin. Pract. Oncol. 6, 53-58 (2009).
88. De, A., Lewis, X. Z. & Gambhir, S. S. Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol. Ther. 7, 681-691 (2003). (Pubitemid 36626248)
89. Kohn, D. B., Sadelain, M. & Glorioso, J. C. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3, 477-488 (2003). (Pubitemid 37328836)
90. Papapetrou, E. P. et al. Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat. Biotechnol. 29, 73-78 (2011).
91. Lam, A. P & Dean, D. A. Progress and prospects: nuclear import of nonviral vectors. Gene Ther. 17, 439-447 (2010).
92. Min, J. J. & Gambhir, S. S. Molecular imaging of PET reporter gene expression. Handb. Exp. Pharmacol. 185/2, 277-303 (2008).
93. Koehne, G. et al. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat. Biotechnol. 21, 405-413 (2003). (Pubitemid 36397661)
94. Ponomarev, V. et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 3, 480-488 (2001). (Pubitemid 33151014)
95. Dobrenkov, K. et al. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J. Nucl. Med. 49, 1162-1170 (2008). (Pubitemid 351948026)
96. Cao, F. et al. Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation. Cloning Stem Cells 9, 107-117 (2007). (Pubitemid 46642075)
97. Brader, P. et al. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin. Cancer Res. 14, 2295-2302 (2008). (Pubitemid 351551060)
98. Rogers, B. E., Chaudhuri, T. R., Reynolds, P. N., Della Manna, D. & Zinn, K. R. Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter. Gene Ther. 10, 105-114 (2003). (Pubitemid 36582582)
99. Zhang, H. et al. Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC. J. Nucl. Med. 52, 123-131 (2011).
100. Moroz, M. A. et al. Imaging hNET reporter gene expression with 124I-MIBG. J. Nucl. Med. 48, 827-836 (2007). (Pubitemid 47604985)
101. Auricchio, A. et al. In vivo quantitative noninvasive imaging of gene transfer by single-photon emission computerized tomography. Hum. Gene Ther. 14, 255-261 (2003). (Pubitemid 36423444)
102. Kummer, C. et al. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector. Mol. Imaging 6, 181-192 (2007). (Pubitemid 47152705)
103. MacLaren, D. C. et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 6, 785-791 (1999). (Pubitemid 29243651)
104. Huang, M. et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther. 8, 612-618 (2001). (Pubitemid 32786564)
105. Doubrovin, M. M. et al. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res. 67, 11959-11969 (2007).
106. Kim, Y. H. et al. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J. Nucl. Med. 46, 305-311 (2005). (Pubitemid 43073441)
107. Terrovitis, J. et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J. Am. Coll. Cardiol. 52, 1652-1660 (2008).
108. Hwang do, W. et al. Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter. Eur. J. Nucl. Med. Mol. Imaging 35, 135-145 (2008).
109. Soenen, S. J. & De Cuyper, M. Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol. Imaging 4, 207-219 (2009).
110. Zhang, L. W., Baumer, W. & Monteiro-Riviere, N. A. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine 6, 777-791 (2011).
111. Zanzonico, P. et al. [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity. Eur. J. Nucl. Med. Mol. Imaging 33, 988-997 (2006).
112. Mercier-Letondal, P. et al. Early immune response against retrovirally-transduced Herpes Simplex Virus-thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response? Hum. Gene Ther. 19, 937-950 (2008).
113. Wu, J. C. et al. Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol. Genomics 25, 29-38 (2006).
114. Segal, A. W., Arnot, R. N., Thakur, M. L. & Lavender, J. P. Indium-111-labelled leucocytes for localisation of abscesses. Lancet 2, 1056-1058 (1976).
115. Muller, C., Zielinski, C. C., Linkesch, W., Ludwig, H. & Sinzinger, H. In vivo tracing of indium-111 oxine-labeled human peripheral blood mononuclear cells in patients with lymphatic malignancies. J. Nucl. Med. 30, 1005-1011 (1989). (Pubitemid 19150002)
116. Youssef, P. P. et al. Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis, and the effects of methylprednisolone. Arthritis Rheum. 39, 216-225 (1996). (Pubitemid 26065261)
117. Blocklet, D. et al. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur. J. Nucl. Med. Mol. Imaging 30, 440-447 (2003). (Pubitemid 36692872)
118. Bulte, J. W. In vivo MRI cell tracking: clinical studies. AJR Am. J. Roentgenol. 193, 314-325 (2009).
119. Stuber, M. et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn. Reson. Med. 58, 1072-1077 (2007). (Pubitemid 350074377)
120. Pichler, B. J., Kolb, A., Nagele, T. & Schlemmer, H. P. PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J. Nucl. Med. 51, 333-336 (2010).
121. Patel, D. et al. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Biomaterials 32, 1167-1176 (2011). 629
122. Deroose, J. P. et al. 20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters. Ann. Surg. Oncol. doi:10.1245/s10434-011-2030-7 630
123. Breitbach, C. J. et al. Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477, 99-102 (2011) 629
124. Ralfkiaer, U. et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood doi:10.1182/blood-2011-06-358382 629
125. Yonesaka, K. et al. Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci. Transl. Med. doi:10.1126/scitranslmed.3002442 628
126. van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat. Med. doi:10.1038/nm.2472